Phosphodiesterase 5 Inhibition in Chronic Heart Failure and Pulmonary Hypertension-Reference-Cited by-同舟云学术

Phosphodiesterase 5 Inhibition in Chronic Heart Failure and Pulmonary Hypertension

Published:2005-12 Issue:12 Volume:96 Page:47-51
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Patel Milan D.,Katz Stuart D.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference46 articles.

1. American Heart Association. Heart Disease and Stroke Statistics: 2004 Update. Available at: http://www.americanheart.org/presenter.jhtml?identifier-3000090. Accessed December 13, 2005.

2. The economic burden of heart failure;O’Connell;Clin Cardiol,2000

3. Preferences for treatment outcomes in patients with heart failure;Stanek;J Card Fail,2000

4. Symptom distress in cardiac transplantation;Grady;Heart Lung,1992

5. Psychosocial adjustment of patients and spouses to severe cardiomyopathy;Bohachick;Res Nurs Health,1990

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Pharmacokinetic and Pharmacodynamic Drug-Drug Interaction of Sacubitril/Valsartan (LCZ696) and Sildenafil in Patients With Mild-to-Moderate Hypertension;Clinical Pharmacology & Therapeutics;2017-11-03

2. Nebulized solid lipid nanoparticles for the potential treatment of pulmonary hypertension via targeted delivery of phosphodiesterase-5-inhibitor;International Journal of Pharmaceutics;2017-01

3. Beyond Erectile Dysfunction: Understanding PDE5 Activity In The Central Nervous System;Cyclic-Nucleotide Phosphodiesterases In The Central Nervous System;2014-03-07

4. Pulmonary vasoconstrictor influence of endothelin in exercising swine depends critically on phosphodiesterase 5 activity;American Journal of Physiology-Lung Cellular and Molecular Physiology;2014-03-01

5. Persistent pulmonary hypertension of the newborn: recent advances in pathophysiology and treatment;Jornal de Pediatria;2013-05